Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
49.30
-1.70 (-3.33%)
At close: Dec 4, 2025
-7.85%
Market Cap 5.30B
Revenue (ttm) 9.52B
Net Income (ttm) 537.75M
Shares Out 107.42M
EPS (ttm) 4.99
PE Ratio 9.89
Forward PE n/a
Dividend 1.40 (2.84%)
Ex-Dividend Date Nov 20, 2025
Volume 279,736
Average Volume 331,215
Open 51.00
Previous Close 51.00
Day's Range 48.90 - 51.50
52-Week Range 42.00 - 65.80
Beta -0.20
RSI 41.97
Earnings Date Jan 22, 2026

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 4,798
Stock Exchange Dhaka Stock Exchange
Ticker Symbol NAVANAPHAR
Full Company Profile

Financial Performance

In 2025, Navana Pharmaceuticals's revenue was 8.84 billion, an increase of 28.19% compared to the previous year's 6.90 billion. Earnings were 487.81 million, an increase of 20.56%.

Financial Statements

News

There is no news available yet.